A Guide to the New Era of Immuno-Oncology in Hepatocellular Carcinoma

Event Information

 

Event Overview

Location:
InterContinental San Francisco  
Room: InterContinental Ballroom (5th Floor)
San Francisco, California 94103
Join our esteemed faculty in this interactive, CME-certified satellite symposium on immune checkpoint inhibitors in advanced HCC!

In this 2-hour, interactive CME-certified symposium, our expert faculty panel will review the mechanism of action and rationale for the use of immunotherapy in HCC, key clinical trial data, and strategies for moving immune checkpoint inhibitors into the clinic for patients with advanced HCC.

Not an official event of the 2017 Gastrointestinal Cancers Symposium. Not sponsored, endorsed, or accredited by ASCO or the Conquer Cancer Foundation.

Thursday, January 19, 2017
6:00 PM - 6:30 PM Registration
6:30 PM - 8:30 PM Symposium

Agenda

Agenda
  • Program Overview
    Ghassan K. Abou-Alfa, MD, MBA, Program Director
  • Overview of Immunotherapy in Cancer
    Osama E. Rahma, MD
  • Clinical Development of Immune Checkpoint Inhibitors in HCC
    Ghassan K. Abou-Alfa, MD, MBA
  • Key Issues and Current Controversies in Moving Immunotherapy Into the Clinic for Patients With Advanced HCC
    Andrew X. Zhu, MD, PhD
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
 
Supported by an educational grant from
There are no fees required to participate in this activity.
There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Allison Hughes prior to the live event at ahughes@pimed.com.